(Q43885239)

27 November 2017

title

The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancer (English)

1 reference

27 November 2017

1 reference

1 reference

Lucinda J. Billingham

series ordinal

1

1 reference

27 November 2017

M H Cullen

2

1 reference

27 November 2017

publication date

1 December 2001

1 reference

27 November 2017

1 reference

27 November 2017

volume

12

1 reference

27 November 2017

issue

12

1 reference

27 November 2017

page(s)

1671-1675

1 reference

Mitomycin, ifosfamide, and cisplatin in unresectable non-small-cell lung cancer: effects on survival and quality of life

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013582618920

7 January 2021

A randomized trial of induction chemotherapy plus high-dose radiation versus radiation alone in stage III non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013582618920

7 January 2021

Survival determinants in extensive-stage non-small-cell lung cancer: the Southwest Oncology Group experience

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013582618920

7 January 2021

Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013582618920

7 January 2021

https://api.crossref.org/works/10.1023%2FA%3A1013582618920

1 reference

7 January 2021

A consumer's guide to subgroup analyses

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1013582618920

7 January 2021

Identifiers

DOI

10.1023/A:1013582618920

1 reference

27 November 2017

1 reference